Fidelity Investments
SKYE icon

Fidelity Investments’s Skye Bioscience SKYE Stock Holding History

Fidelity Investments’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 5563
2026
Q1 		– Sell
-94
Closed -$561 – 5592
2025
Q4 		$561 Sell
94
-1,392
-94% -$16.3K ﹤0.01% 5144
2025
Q3 		$46.7K Hold
1,486
– – ﹤0.01% 4002
2025
Q2 		$49.7K Buy
1,486
+1,103
+288% +$18.3K ﹤0.01% 3910
2025
Q1 		$4.87K Buy
383
+114
+42% +$2.49K ﹤0.01% 4713
2024
Q4 		$6.09K Buy
269
+232
+627% +$7.75K ﹤0.01% 4622
2024
Q3 		$1.15K Buy
+37
New +$1.66K ﹤0.01% 4888

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Fidelity Investments's SKYE Position: Q2 2026 in Review

Fidelity Investments held its Skye Bioscience (SKYE) position steady in Q2 2026 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5563.

Fidelity Investments first reported a position in SKYE in Q3 2024 and has held it in 6 quarters since. The position peaked at $49.7K in Q2 2025. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Fidelity Investments held 0 shares of Skye Bioscience worth $1 as of Q2 2026.
  • Fidelity Investments left its Skye Bioscience share count unchanged in Q2 2026.
  • Skye Bioscience made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5563 holding.
  • Fidelity Investments first reported a position in Skye Bioscience in Q3 2024 and has held it in 6 quarters since.
  • Fidelity Investments's Skye Bioscience position peaked at $49.7K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.